Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
January 5th, 2015
15.6K views
The use of fluorophores for in vivo imaging can be greatly limited by opsonization, rapid clearance, low detection sensitivity and cytotoxic effects on the host. Encapsulation of fluorophores in liposomes by film hydration and extrusion leads to fluorescence quenching and protection which enables in vivo imaging with high detection sensitivity.
Overview
This article discusses the preparation of activatable liposomes for in vivo imaging of inflammation with high sensitivity. The method involves creating a lipid film and hydrating it with a near-infrared fluorescent dye to form liposomes that can effectively encapsulate the dye.
Key Study Components
Area of Science
- Neuroscience
- Biochemistry
- Imaging Techniques
Background
- Fluorophores are often limited by opsonization and rapid clearance in vivo.
- Encapsulation in liposomes can enhance detection sensitivity.
- Near-infrared fluorescence imaging is a promising technique for visualizing biological processes.
- Understanding liposome behavior can improve imaging of inflammation.
Purpose of Study
- To prepare liposomes that enhance in vivo imaging sensitivity.
- To demonstrate the potential of these liposomes for imaging inflammatory processes.
- To evaluate the quenching state of encapsulated dyes during imaging.
Methods Used
- Preparation of a lipid film composed of phospholipids.
- Hydration of the lipid film with a quenched concentration of a near-infrared dye.
- Extrusion of spontaneously formed vesicles to ensure homogeneity.
- Purification of liposomes from non-encapsulated dye molecules.
Main Results
- Successful formation of homogenous liposomal vesicles.
- Demonstration of high sensitivity in detecting inflammation using near-infrared fluorescence imaging.
- Quantitative analysis of the quenching state of the encapsulated dye.
- Potential applications in studying inflammatory processes in vivo.
Conclusions
- Encapsulated liposomes significantly improve imaging sensitivity.
- This method can be applied to various biological imaging applications.
- Further research is needed to optimize liposome formulations for specific imaging needs.
Frequently Asked Questions
What are liposomes?
Liposomes are spherical vesicles composed of lipid bilayers that can encapsulate drugs or dyes for delivery.
How does near-infrared fluorescence imaging work?
It utilizes near-infrared light to excite fluorescent dyes, allowing for imaging of biological processes with high sensitivity.
What is the significance of dye encapsulation?
Encapsulation protects the dye from rapid clearance and enhances detection sensitivity during imaging.
What are the applications of this study?
The findings can be applied to improve imaging techniques for studying inflammation and other biological processes.
What challenges do fluorophores face in vivo?
Challenges include opsonization, rapid clearance, low detection sensitivity, and potential cytotoxic effects.
How are the liposomes purified?
Liposomes are purified from residual non-encapsulated dye molecules after the extrusion process.
What is the overall goal of this procedure?
The goal is to prepare activatable liposomes for enhanced in vivo imaging of inflammation.
Executive Industry Relevance
This method addresses the challenge of rapid clearance and low sensitivity in preclinical fluorescent probes by encapsulating self-quenching near-infrared dye in liposomes, enabling activatable imaging upon cellular uptake. The approach enhances target-specific signal detection while minimizing background fluorescence, supporting improved predictive confidence in inflammation models. It provides a mechanistic de-risking tool for validating phagocyte-mediated delivery and inflammatory biomarker engagement in preclinical studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of phagocytic uptake mechanisms to validate macrophage-related targets in inflammation.
- Operational Value: Provides a quantifiable readout of cellular internalization via fluorescence activation, reducing reliance on indirect biomarkers.
- Predictive Value: Supports target confidence by linking probe activation to functional cellular processes rather than passive accumulation.
Screening & Assay Development
- Scientific Value: Generates standardized, quenchant-protected liposomes with consistent dye loading for reproducible assay performance.
- Operational Value: Facilitates high-throughput screening of modulators affecting liposome uptake or activation in phagocytic cell lines.
- Assay Readiness: Produces purified liposomal formulations suitable for downstream fluorescence-based screening workflows.
Translational & Preclinical Research
- Translational Value: Demonstrates disease-relevant inflammation imaging in murine edema models, supporting continuity from cellular to whole-organism validation.
- Mechanistic De-risking: Distinguishes specific phagocyte-mediated activation from nonspecific EPR effects using Lip-Q versus Lip-dQ controls.
- Risk-Adjusted Advancement: Enables go/no-go decisions based on temporal signal profiles and background suppression in vivo.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead identification to preclinical imaging, particularly for inflammation-modulating therapeutics where phagocyte engagement is a mechanism of action.
- Discovery Biology: Supports hypothesis testing of phagocyte-dependent pathways by providing activation-only signal upon cellular internalization.
- Screening: Enables assay development for compounds that modulate liposome uptake or quenching reversal in macrophage models.
- Analytics: Delivers quantitative fluorescence emission and absorbance measurements to compare quenching states and activation kinetics.
- Translational Research: Connects in vitro phagocytic uptake to in vivo inflammation imaging via zymosan-induced edema model.
- Enterprise Reuse: Establishes a reusable platform for activatable near-infrared probes applicable to multiple disease models involving phagocyte recruitment.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by isolating signal to activated probes within target cells, reducing false positives from circulating probe.
- Operational Value: Ensures reproducibility through standardized extrusion, purification, and quenching validation steps.
- Strategic Value: Improves capital efficiency by enabling early detection of target engagement, reducing late-stage failure due to lack of biological specificity.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates based on validated inflammatory target modulation and phagocyte delivery.
Implementation Considerations
- Requires expertise in lipid film preparation, probe quenching optimization, and fluorescence spectroscopy.
- Depends on access to extrusion equipment, ultracentrifugation, and spectral fluorimeters for validation.
- Necessitates standardization across teams for liposome size, dye concentration, and quenching efficiency.
- Requires adaptation testing when extending to non-phagocytic cell types or alternative disease models.
- Practical limitation: signal depends on cellular internalization and quenching reversal, which may vary with cell health or microenvironment.
Biopharma FAQs
Why does quenching efficiency matter for target validation in inflammation models?
Quenching efficiency ensures that fluorescence signal originates only from de-quenched dye following cellular uptake and lysosomal degradation, minimizing background from circulating or non-internalized probes. This allows specific attribution of signal to phagocytic activity, a key mechanism in inflammation. The method uses spectrometric measurements to confirm the quenched state of encapsulated dye prior to imaging.
How does isolation of the independent variable (liposome formulation) support discovery pipeline decisions?
By comparing Lip-Q (quenched), Lip-dQ (non-quenched control), and free dye, the method isolates the effect of quenching and phagocyte-dependent activation on signal generation. This enables clear assessment of whether observed imaging signals depend on cellular processing rather than passive accumulation. Such isolation supports mechanistic de-risking in lead identification.
What quantitative dependent variable measurements enable assessment of probe activation?
Fluorescence emission spectra excited at 674 nm and measured from 694 to 800 nm, along with absorbance scans from 400 to 900 nm, provide quantitative readouts of quenching and activation states. These measurements confirm spectral shifts indicative of dye de-quenching upon liposomal disruption. The data allow comparison across formulations and time points to assess activation kinetics.
Why are replication requirements important for cross-functional collaboration in probe development?
Replication across extrusion cycles, purification steps, and instrument runs ensures consistent liposome homogeneity, quenching efficiency, and dye loading—critical for reproducible results between chemistry, biology, and imaging teams. The protocol specifies 10 extrusion cycles and gel chromatography purification to achieve batch-to-batch consistency. This standardization enables reliable handoff between discovery and preclinical teams.
What statistical analysis capabilities are required before implementing this imaging approach?
Implementation requires capability to quantify fluorescence intensity over time, compare signal-to-noise ratios between inflamed and control tissues, and assess significant differences in activation kinetics across liposome formulations. The method relies on longitudinal imaging every two hours for 10 hours and at 24 hours post-injection to establish temporal profiles. Statistical comparison of these time-series data supports validation of probe performance in vivo.
Chapters in this video
0:05
Title
2:08
Preparation of Spontaneously Formed Vesicle (SFV) Dispersion
3:54
Extrusion and Purification of Homogeneous Liposome Vesicles Encapsulating DY-676-COOH
5:21
Physico-chemical Analysis of Flourescence Quenching and Activation
7:10
Induction of Inflammation and In Vivo NIRF Imaging
8:10
Results: Representative Liposomal Flourescence Quenching Analyses
9:54
Conclusion
